Per‐Erik Andersson

484 total citations
13 papers, 397 citations indexed

About

Per‐Erik Andersson is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Per‐Erik Andersson has authored 13 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Per‐Erik Andersson's work include Blood Pressure and Hypertension Studies (2 papers), Diabetes Treatment and Management (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). Per‐Erik Andersson is often cited by papers focused on Blood Pressure and Hypertension Studies (2 papers), Diabetes Treatment and Management (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). Per‐Erik Andersson collaborates with scholars based in Sweden, Switzerland and Finland. Per‐Erik Andersson's co-authors include Hans Lithell, Annika Wærn, A. Hemmingsson, Tapani Keränen, Jukka Jolkkonen, Jensen Pk, G. P. Menge, Arvo Haenni, Lars Lind and Richard Reneland and has published in prestigious journals such as Metabolism, Journal of Hypertension and American Journal of Hypertension.

In The Last Decade

Per‐Erik Andersson

13 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per‐Erik Andersson Sweden 8 193 119 95 59 56 13 397
U. Honrath Canada 13 252 1.3× 66 0.6× 189 2.0× 86 1.5× 60 1.1× 32 559
Sabine Wessels Germany 9 203 1.1× 85 0.7× 107 1.1× 194 3.3× 77 1.4× 9 586
Y Ozawa Japan 11 219 1.1× 92 0.8× 39 0.4× 55 0.9× 28 0.5× 18 362
Tetsutaro Matayoshi Japan 12 192 1.0× 104 0.9× 68 0.7× 41 0.7× 28 0.5× 25 403
Masami Ohrui Japan 11 170 0.9× 91 0.8× 24 0.3× 43 0.7× 38 0.7× 21 444
G. C. Viberti United Kingdom 10 212 1.1× 182 1.5× 67 0.7× 177 3.0× 24 0.4× 16 607
Kaoru Yoshinaga Japan 9 121 0.6× 139 1.2× 65 0.7× 49 0.8× 17 0.3× 30 353
Pedro Forcada Argentina 11 173 0.9× 34 0.3× 52 0.5× 45 0.8× 32 0.6× 31 424
G Nomura Japan 15 244 1.3× 103 0.9× 99 1.0× 88 1.5× 34 0.6× 40 625
Darryl Meeking United Kingdom 10 156 0.8× 124 1.0× 28 0.3× 19 0.3× 12 0.2× 32 453

Countries citing papers authored by Per‐Erik Andersson

Since Specialization
Citations

This map shows the geographic impact of Per‐Erik Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per‐Erik Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per‐Erik Andersson more than expected).

Fields of papers citing papers by Per‐Erik Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per‐Erik Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per‐Erik Andersson. The network helps show where Per‐Erik Andersson may publish in the future.

Co-authorship network of co-authors of Per‐Erik Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Per‐Erik Andersson. A scholar is included among the top collaborators of Per‐Erik Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per‐Erik Andersson. Per‐Erik Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gao, Chuansi, et al.. (2014). Using a walkway with adjustable inclination to measure and assess slip and fall risks. Lund University Publications (Lund University). 1 indexed citations
2.
Hedman, Anu, Per‐Erik Andersson, Richard Reneland, & Hans Lithell. (2001). Insulin-mediated changes in leg blood flow are coupled to capillary density in skeletal muscle in healthy 70-year-old men. Metabolism. 50(9). 1078–1082. 16 indexed citations
3.
Andersson, Per‐Erik, et al.. (1999). Both leg blood flow and the femoral blood flow pattern are related to left ventricular mass in elderly men. Clinical Physiology. 19(3). 275–276. 3 indexed citations
4.
Andersson, Per‐Erik. (1998). Aspects of Insulin Resistance with Special Reference to the Vasoactive Effects of Insulin. Medical Entomology and Zoology. 2 indexed citations
5.
Reneland, Richard, et al.. (1997). Circulating angiotensin converting enzyme levels are increased in concentric, but not eccentric, left ventricular hypertrophy in elderly men. Journal of Hypertension. 15(8). 885–890. 13 indexed citations
6.
Lithell, Hans & Per‐Erik Andersson. (1997). Metabolic effects of carvedilol in hypertensive patients. European Journal of Clinical Pharmacology. 52(1). 13–17. 7 indexed citations
7.
Haenni, Arvo, Lars Berglund, Richard Reneland, et al.. (1997). Alterations in insulin sensitivity during ACE inhibitor treatment are related to changes in magnesium status. 190. 1 indexed citations
8.
Andersson, Per‐Erik. (1996). Metabolic Effects of Doxazosin and Enalapril in Hypertriglyceridemic, Hypertensive Men Relationship to Changes in Skeletal Muscle Blood Flow. American Journal of Hypertension. 9(4). 323–333. 49 indexed citations
9.
Andersson, Per‐Erik, et al.. (1995). Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. Journal of Hypertension. 13(4). 433???438–433???438. 133 indexed citations
10.
Haenni, Arvo, Per‐Erik Andersson, Lars Lind, Christian Berne, & Hans Lithell. (1994). Electrolyte Changes and Metabolic Effects of Lisinopril/Bendrofluazide Treatment Results From a Randomized, Double-Blind Study With Parallel Groups. American Journal of Hypertension. 7(7_Pt_1). 615–622. 32 indexed citations
11.
Keränen, Tapani, Jukka Jolkkonen, Jensen Pk, G. P. Menge, & Per‐Erik Andersson. (1992). Absence of interaction between oxcarbazepine and erythromycin. Acta Neurologica Scandinavica. 86(2). 120–123. 52 indexed citations
12.
Lofdahl, CG, et al.. (1984). Comparison of beta 2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies.. PubMed. 135. 124–7. 2 indexed citations
13.
Wærn, Annika, Per‐Erik Andersson, & A. Hemmingsson. (1983). Takayasu's Arteritis: A Hospital-Region Based Study on Occurrence, Treatment and Prognosis. Angiology. 34(5). 311–320. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Honrath Breakdown of academic impact, for papers by Sabine Wessels Breakdown of academic impact, for papers by Y Ozawa Breakdown of academic impact, for papers by Tetsutaro Matayoshi Breakdown of academic impact, for papers by Masami Ohrui Breakdown of academic impact, for papers by G. C. Viberti Breakdown of academic impact, for papers by Kaoru Yoshinaga Breakdown of academic impact, for papers by Pedro Forcada Breakdown of academic impact, for papers by G Nomura Breakdown of academic impact, for papers by Darryl Meeking
Rankless by CCL
2026